Literature DB >> 15134714

Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.

Nilda Turgut1, Serap Karasalihoglu, Yasemin Kücükugurluoglu, Kemal Balci, Galip Ekuklu, Filiz Tütüncüler.   

Abstract

OBJECTIVE: Monitoring of the dorsal sural sensory nerve action potential (SNAP) is a sensitive method for detection of peripheral neuropathies. We tried to determine the normal dorsal sural nerve conduction values of the childhood population and assessed the clinical utility of this method in diabetic children who have no clinical sign of peripheral neuropathy.
METHODS: In the study, 36 healthy and 27 diabetic children were included. In all subjects peripheral motor and sensory nerve studies were performed on the upper and lower limbs including dorsal sural nerve conduction studies.
RESULTS: The dorsal sural SNAP mean amplitude was 8.24+/-3.08 microV, mean latency was 2.47+/-0.48 ms, mean sensory conduction velocity was 41.63+/-5.43 m/s in healthy children. Dorsal sural SNAPs were absent bilaterally in one diabetic patient. In the other 26 diabetic patients, the mean dorsal sural nerve distal latency was longer (2.93+/-0.63 ms, P = 0.004), mean SCV was slower than in healthy subjects (36.68+/-7.66 m/s, P = 0.005). However, dorsal sural nerve amplitude was not different between the groups. A dorsal sural nerve latency of more than 2.9 ms had a sensitivity of 50% and a specificity of 75%. A dorsal sural nerve velocity of less than 36 m/s had a sensitivity of 54% and a specificity of 92%.
CONCLUSIONS: We designated the reference values of the dorsal sural nerve in healthy children. In addition, our findings suggest that dorsal sural nerve conduction studies may have value to determine neuropathy in the early stages in children with diabetes. SIGNIFICANCE: The dorsal sural nerve conduction studies in diabetic children may have value to determine the neuropathy in its early stages.

Entities:  

Mesh:

Year:  2004        PMID: 15134714     DOI: 10.1016/j.clinph.2004.01.003

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve.

Authors:  Paola Alberti; Emanuela Rossi; Andreas A Argyriou; Haralabos P Kalofonos; Chiara Briani; Mario Cacciavillani; Marta Campagnolo; Jordi Bruna; Roser Velasco; Marina E Cazzaniga; Diego Cortinovis; Maria G Valsecchi; Guido Cavaletti
Journal:  Support Care Cancer       Date:  2018-03-29       Impact factor: 3.603

Review 2.  Diabetic foot biomechanics and gait dysfunction.

Authors:  James S Wrobel; Bijan Najafi
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

3.  Gait characteristics in people with type 2 diabetes mellitus.

Authors:  Jerrold Petrofsky; Scott Lee; Salameh Bweir
Journal:  Eur J Appl Physiol       Date:  2004-12-01       Impact factor: 3.078

4.  Assessment of the medial dorsal cutaneous, dorsal sural, and medial plantar nerves in impaired glucose tolerance and diabetic patients with normal sural and superficial peroneal nerve responses.

Authors:  Sun Im; Sung-Rae Kim; Joo Hyun Park; Yang Soo Kim; Geun-Young Park
Journal:  Diabetes Care       Date:  2011-11-18       Impact factor: 19.112

5.  Dorsal Sural Sensory Nerve Action Potential: A Study for Reference Values.

Authors:  Sweta Chetan Chaudhari; Khushnuma Anil Mansukhani; Alika Sharma; Lajita Balakrishnan; Aarthika Sreenivasan
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

6.  Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.

Authors:  Yi-Ching Weng; Sung-Sheng Tsai; Rong-Kuo Lyu; Chun-Che Chu; Long-Sun Ro; Ming-Feng Liao; Hong-Shiu Chang; Chiung-Mei Chen; Jawl-Shan Hwang; Hung-Chou Kuo
Journal:  J Diabetes Res       Date:  2020-07-03       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.